Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEquity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Pharming (PHAR) Other Non Operating Income (2020 - 2024)

Historic Other Non Operating Income for Pharming (PHAR) over the last 7 years, with Q3 2025 value amounting to -$119000.0.

  • Pharming's Other Non Operating Income fell 66666.67% to -$119000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.6 million, marking a year-over-year decrease of 7371.84%. This contributed to the annual value of $5.0 million for FY2024, which is 63655.91% up from last year.
  • Pharming's Other Non Operating Income amounted to -$119000.0 in Q3 2025, which was down 66666.67% from $1.3 million recorded in Q2 2025.
  • Pharming's Other Non Operating Income's 5-year high stood at $5.1 million during Q2 2024, with a 5-year trough of -$9.7 million in Q2 2022.
  • Its 5-year average for Other Non Operating Income is -$366097.7, with a median of $21000.0 in 2024.
  • Data for Pharming's Other Non Operating Income shows a peak YoY increase of 3946367.2% (in 2022) and a maximum YoY decrease of 2764298.42% (in 2022) over the last 5 years.
  • Pharming's Other Non Operating Income (Quarter) stood at -$8.2 million in 2021, then soared by 60.44% to -$3.2 million in 2022, then surged by 71.19% to -$930000.0 in 2023, then skyrocketed by 81.83% to -$169000.0 in 2024, then increased by 29.59% to -$119000.0 in 2025.
  • Its Other Non Operating Income was -$119000.0 in Q3 2025, compared to $1.3 million in Q2 2025 and $604000.0 in Q1 2025.